(Q44924019)
Statements
Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma (English)
Ayres JG
Higgins B
Ayre G
Blogg M
1 reference
1 reference
1 reference
1 reference
1 reference